Literature DB >> 12065470

Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice.

Tao Peng1, Lisa Shubitz, Julie Simons, Robert Perrill, Kris I Orsborn, John N Galgiani.   

Abstract

Subunits of a proline-rich coccidioidal antigen (Ag2/PRA) of Coccidioides immitis were analyzed by comparison as vaccines in mice. The optimal dose of plasmid vaccine encoding full-length Ag2/PRA was determined to be between 10 and 100 microg. Mice vaccinated with plasmids encoding amino acids (aa) 1 to 106 were as protective as full-length Ag2/PRA (aa 1 to 194). The subunit from aa 27 to 106 was significantly but less protective. Plasmids encoding aa 90 to 151 or aa 90 to 194 were not protective. Analogous results were obtained with recombinant vaccines of the same amino acid sequences. In addition, mixtures of aa 90 to 194 with either aa 1 to 106 or aa 27 to 106 did not enhance protection compared to the active single-recombinant subunits alone. Humoral response of total immunoglobulin G (IgG) and subclasses IgG1 and IgG2a were detectable in subunit vaccinations but at significantly (100-fold) lower concentrations than after vaccination with plasmids encoding full-length Ag2/PRA. Since virtually all protection by vaccination with full-length Ag2/PRA can be accounted for in the first half of the protein (aa 1 to 106), this subunit could make a multicomponent vaccine more feasible by reducing the quantity of protein per dose and the possibility of an untoward reactions to a foreign protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065470      PMCID: PMC128045          DOI: 10.1128/IAI.70.7.3330-3335.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.

Authors:  D Pappagianis
Journal:  Fungal Genet Biol       Date:  2001-02       Impact factor: 3.495

2.  Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.

Authors:  C Jiang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 3.  Coccidioides immitis as a Select Agent of bioterrorism.

Authors:  D M Dixon
Journal:  J Appl Microbiol       Date:  2001-10       Impact factor: 3.772

4.  IMMUNIZATION OF MICE TO COCCIDIOIDES IMMITIS: DOSE, REGIMEN AND SPHERULATION STAGE OF KILLED SPHERULE VACCINES.

Authors:  H B LEVINE; Y C KONG; C SMITH
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

5.  Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America.

Authors:  J N Galgiani; N M Ampel; A Catanzaro; R H Johnson; D A Stevens; P L Williams
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

6.  An epidemic of coccidioidomycosis among archeology students in northern California.

Authors:  S B Werner; D Pappagianis; I Heindl; A Mickel
Journal:  N Engl J Med       Date:  1972-03-09       Impact factor: 91.245

7.  Coccidioidomycosis in workers at an archeologic site--Dinosaur National Monument, Utah, June-July 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-11-16       Impact factor: 17.586

8.  Identification and characterization of TUP1-regulated genes in Candida albicans.

Authors:  B R Braun; W S Head; M X Wang; A D Johnson
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

9.  Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.

Authors:  Lisa Shubitz; Tao Peng; Robert Perrill; Julie Simons; Kris Orsborn; John N Galgiani
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

10.  Coccidioidomycosis at a university health service.

Authors:  S S Kerrick; L L Lundergan; J N Galgiani
Journal:  Am Rev Respir Dis       Date:  1985-01
View more
  7 in total

Review 1.  An insight into the antifungal pipeline: selected new molecules and beyond.

Authors:  Luis Ostrosky-Zeichner; Arturo Casadevall; John N Galgiani; Frank C Odds; John H Rex
Journal:  Nat Rev Drug Discov       Date:  2010-08-20       Impact factor: 84.694

Review 2.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

Review 3.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.

Authors:  Lisa F Shubitz; Daniel A Powell; Hien T Trinh; M Lourdes Lewis; Marc J Orbach; Jeffrey A Frelinger; John N Galgiani
Journal:  Vaccine       Date:  2018-04-30       Impact factor: 3.641

5.  Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.

Authors:  Roger A Herr; Chiung-Yu Hung; Garry T Cole
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

6.  Dothideomycete plant interactions illuminated by genome sequencing and EST analysis of the wheat pathogen Stagonospora nodorum.

Authors:  James K Hane; Rohan G T Lowe; Peter S Solomon; Kar-Chun Tan; Conrad L Schoch; Joseph W Spatafora; Pedro W Crous; Chinappa Kodira; Bruce W Birren; James E Galagan; Stefano F F Torriani; Bruce A McDonald; Richard P Oliver
Journal:  Plant Cell       Date:  2007-11-16       Impact factor: 11.277

Review 7.  Animal models: an important tool in mycology.

Authors:  Javier Capilla; Karl V Clemons; David A Stevens
Journal:  Med Mycol       Date:  2007-12       Impact factor: 4.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.